All In Biotech

Free tool

FAERS Monitor: Gloperba

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210942 or its brand name (Gloperba, Colchicine). Reports on generic versions are filed under their own applications.

Reports

26,563

Serious

21,606

81% of reports

Hospitalization

11,631

Death reported

3,267

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea2,429
  • off label use2,256
  • drug ineffective2,052
  • nausea1,809
  • fatigue1,643
  • dyspnoea1,371
  • arthralgia1,356
  • acute kidney injury1,318
  • headache1,279
  • vomiting1,240
  • toxicity to various agents1,230
  • pain1,135
  • drug interaction1,119
  • gout1,109
  • rash993

Reports by year received

View as table
YearReports
2004223
2005284
2006236
2007232
2008253
2009419
2010536
2011816
2012695
2013564
2014625
2015970
20161,281
20171,272
20181,594
20192,117
20202,139
20211,802
20221,952
20232,096
20242,220
20252,493
20261,743

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,027,596 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
goutSignal1,10952.149.152,132
acute kidney injurySignal1,3186.96.56,596
toxicity to various agentsSignal1,2305.85.54,897
drug interactionSignal1,1195.65.34,245
diarrhoeaSignal2,4293.02.93,298
arthralgiaSignal1,3562.62.51,341
vomitingSignal1,2402.12.0719
off label useSignal2,2562.02.01,249
dyspnoea1,3711.91.8619
nausea1,8091.81.7681
rash9931.81.7363
fatigue1,6431.71.6460
headache1,2791.61.5309
pain1,1351.51.4171
drug ineffective2,0521.21.296

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.